Supplements on GLP-1 Drugs: The Complete Guide (Ozempic, Wegovy, Mounjaro)
If you are on a GLP-1 drug such as Ozempic, Wegovy, or Mounjaro, the supplement question is not "what burns more fat" — the medication already handles weight loss — it is how to protect your body while you lose weight quickly. The evidence points to five practical priorities: preserve muscle with adequate protein, cover the micronutrient gaps that appetite loss opens up, manage the gut side effects, understand why hair sheds (and why biotin will not fix it), and steer clear of a few genuinely risky supplement combinations. This guide summarizes each and links the full evidence-based deep dive, none of which replaces the advice of the clinician who prescribed your medication.
GLP-1 receptor agonists have changed weight management, but rapid weight loss by any means takes more than fat with it — and the powerful appetite suppression that makes these drugs work also makes it hard to eat enough of the right things. That is the real role for supplements here: not to accelerate the loss, but to defend muscle, nutrition, and tolerability along the way. Here are the five things that actually matter, in priority order.
1. Preserve muscle
Up to roughly 40% of the weight lost on a GLP-1 drug can be lean mass, and trial participants have shed about 10% or more of their muscle over a year. The defense is not a pill: it is enough protein (clinicians target around 1.6 g per kg of body weight per day) plus resistance training, with creatine, HMB, vitamin D, and omega-3 as modest adjuncts. Read the full guide on preserving muscle on GLP-1 drugs →
2. Cover the micronutrient gaps
Eating far less means taking in fewer vitamins and minerals. The evidence flags vitamin D (the most common deficiency), iron, B12, and calcium as the ones to watch, and the smart move is to keep a foundation of vitamin D plus a basic multivitamin and to test rather than guess. Read the full guide on micronutrient gaps and what to monitor →
3. Manage the gut side effects
Nausea and constipation are the most common reasons people struggle with these drugs. Ginger has moderate evidence for nausea; constipation responds to fluid, fiber such as psyllium, and magnesium — while severe symptoms are a reason to call the prescriber, not reach for a supplement. Read the full guide on managing nausea and constipation →
4. Understand the hair shedding
Around 70% of real-world users report some hair shedding — far more than the trials suggested — but it is almost always reversible telogen effluvium from rapid weight loss, not follicle damage. Biotin and collagen do not fix it; protein, correcting a tested iron or zinc deficiency, and time do. Read the full guide on hair loss and what actually helps →
5. Avoid the risky combinations
A few stacks are worth actively avoiding: doubling up on blood-sugar-lowering supplements (berberine, gymnema, bitter melon) on top of a GLP-1 drug, mistiming oral semaglutide so supplements blunt its absorption, and piling on bulk fiber or stimulant "fat burners" that worsen side effects. Read the full safety guide on what not to stack →
The throughline
Notice what unites all five: the supplements that help are the unglamorous, well-evidenced basics — protein, vitamin D, iron when it is low, ginger, fiber — used to protect the body during fast weight loss, while the products marketed specifically at GLP-1 users (biotin gummies, "muscle preservation" blends, natural-Ozempic boosters) mostly miss the point. Keep the foundation simple, test rather than guess, and bring your full supplement list to the clinician managing your medication.
Sources
- Mechanick JI, Butsch WS, Christensen SM, et al. "Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity." Obesity Reviews, 2024;26(1):e13841. PMID 39295512.
- Urbina J, Salinas-Ruiz LE, Valenciano C, Clapp B. "Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review." Clinical Obesity, 2026;16(1):e70070. PMID 41549912.
- Ghusn W, Hurtado MD. "Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks." Obesity Pillars, 2024;12:100127. PMID 39286601.